Gene Therapy For Beta-Thalassemia: Updated Perspectives

Allogeneic hematopoietic stem cell transplantation was until very recently, the only permanent curative option available for patients suffering from transfusion-dependent beta-thalassemia. Gene therapy, by autologous transplantation of genetically modified hematopoietic stem cells, currently represe...

Descripción completa

Detalles Bibliográficos
Autores principales: Karponi, Garyfalia, Zogas, Nikolaos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6765258/
https://www.ncbi.nlm.nih.gov/pubmed/31576160
http://dx.doi.org/10.2147/TACG.S178546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6765258/
https://www.ncbi.nlm.nih.gov/pubmed/31576160
http://dx.doi.org/10.2147/TACG.S178546

Ejemplares similares